Michael K. Hansen

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

Hiddo J.L. Heerspink, Paul Perco, Skander Mulder et al. · Diabetologia · 2019 · 453 citations · Full text

Medicine, Molecular Biology, Pharmacology +17

Adipose Mitochondrial Biogenesis Is Suppressed in <i>db/db</i> and High-Fat Diet–Fed Mice and Improved by Rosiglitazone

James X. Rong, Yang Qiu, Michael K. Hansen et al. · Diabetes · 2007 · 332 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Peripheral and central proinflammatory cytokine response to a severe acute stressor

Kevin O’Connor, John D. Johnson, Michael K. Hansen et al. · Brain Research · 2003 · 248 citations

Veterinary Medicine, Immunology, Physiology +14

Vagotomy Blocks the Induction of Interleukin-1β (IL-1β) mRNA in the Brain of Rats in Response to Systemic IL-1β

Michael K. Hansen, Ping Taishi, Zutang Chen et al. · Journal of Neuroscience · 1998 · 193 citations · Full text

Life Sciences, Neurobiology, Neuroscience +11

Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes

Susan C. Connor, Michael K. Hansen, Adam S. Corner et al. · Molecular BioSystems · 2010 · 192 citations

Life Sciences, Biochemistry, Metabolomics +16